Art-based program for adults with age-related vision loss
Part of Eyes & vision clinical trials.
This trial tests whether an expressive arts-based program can help adults who have age-related macular degeneration (a common cause of vision loss) by supporting wellbeing and daily functioning. If you meet the language, vision, and health requirements, participating may help you benefit from a structured arts intervention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a community-dwelling adult (not in a residential care setting)
- You speak and can understand Chinese
- You are between 50 and 80 years old
- You have age-related macular degeneration in one or both eyes
- You are not totally blind and you don’t have other major health or thinking/mental health problems that would stop you from finishing the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how age-related macular degeneration (AMD) affects daily activities. If you have AMD and your vision is at least 4/10, you may be able to join to help researchers understand the impact on everyday life.
This study looks at something called 'visual frailty' in older adults with advanced age-related macular degeneration (AMD). It aims to develop a tool to better understand how vision loss affects daily life and overall health in people aged 60 and over.
This study focuses on people age 50+ with early “wasting away” changes in the macula (central retina) called atrophic lesions. It aims to better understand how these early changes progress and how they affect vision testing, which may help improve future treatments.
This study tests whether a remote program that helps you eat healthier can slow the progression of macular degeneration. You'll have online meetings and track your diet, and the study provides support and tools to help you make changes.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.